Announcements
- Immutep Announces Positive Preliminary Topline Results from TACTI-003 Cohort B
- Immutep Reports Promising Clinical Data from INSIGHT-003 Trial at ESMO Congress 2023
- Immutep’s Efti in Combination with KEYTRUDA® Generates Excellent Overall Survival Benefit in Patients with Metastatic Non-Small Cell Lung Cancer
Key statistics
On Monday, Immutep Ltd (PRRUF:PKC) closed at 0.1831, 7.69% above its 52-week low of 0.17, set on Oct 06, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 0.1832 |
---|---|
High | 0.1832 |
Low | 0.1831 |
Bid | -- |
Offer | -- |
Previous close | 0.1831 |
Average volume | -- |
---|---|
Shares outstanding | 1.45bn |
Free float | 1.41bn |
P/E (TTM) | -- |
Market cap | 421.26m AUD |
EPS (TTM) | -0.039 AUD |
Data delayed at least 15 minutes, as of Jul 08 2024 20:20 BST.
More ▼